Teligent, Inc. (NASDAQ: TLGT) was founded in 1977, formerly known as IGI Laboratories, Inc., changed to its current name in October 2015, headquartered in Buena, New Jersey, USA, with 183 full-time employees, is a professional generic drug The company develops, produces and sells generic topical, brand generic and generic injection drugs in the United States and Canada.
Teligent, Inc. (TLGT):
Teligent mainly sells generic drugs, including topical drugs, ophthalmic drugs, compound drugs and injections.
Teligent also develops, manufactures, fills and packages topical semi-solid and liquid products for branded and generic customers as well as over-the-counter drugs and cosmetics markets.
Teligent’s products are used in a variety of applications, from cosmetics and cosmeceuticals to conditional prescription treatments such as dermatitis, psoriasis and eczema.
In addition, Teligent also provides contract manufacturing and formulation services.
Teligent, Inc. sells its products through national chain pharmacies, drug wholesalers, distributors and group purchasing organizations.